Enapotamab vedotin
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). Enapotamab vedotin also exhibits resistant to EGFR inhibitor such as Osimertinib.
1912424-97-5
HuMax-AXL-ADC
12352203
Antibody-Drug Conjugates (ADCs) ; TAM Receptor
Antibody-drug Conjugate/ADC Related; Protein Tyrosine Kinase/RTK
Cancer-programmed cell death
Cancer
[Enapotamabvedotin]
[1]Koopman LA, et al. Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. JCI Insight. 2019 Nov 1;4 (21) :e128199.
Dry Ice
http://file.medchemexpress.com/batch_PDF/HY-P99921/
ADC Related
Phase 2
Beschrijving
Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). En
Specificaties
Recent bekeken producten
Benzonase ELISA Kit
EG23601S
96 Tests
Not I Restriction Enzyme
B2016623
500 Units
K562-HLA-G0101 Overexpressing Cell Line
RG-1214
5x 10^6
Yeast Poly (A) Polymerase
RNT-006-S
30000 Units
Arachis hypogaea Lectin (PNA) - Biotinylated
21510020-1
5mg
Arachis hypogaea lectin (PNA)
05-0116-10mg
10 mg
Anti-APOE2 mouse monoclonal antibody
TD-AB0132
100 µg
Human Apolipoprotein E2 (Apo E2) Antibody
22210-05011
150 µg